Cite
MLA Citation
Olga Uspenskaya‐Cadoz et al.. “Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial).” Alzheimer's & dementia, vol. 16, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100115137935.0x000040